×
Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

China Genetic Counseling Market

ID: MRFR/LS/50618-HCR
200 Pages
Rahul Gotadki
October 2025

China Genetic Counseling Market Research Report By Counseling Approach (Integrated, Independent, Discretionary Genetic Counseling), By Key Players Business Model (Core Genetic Counseling Companies, Direct-to-Consumer Genetic Testing Companies, Clinical Genetic Testing Companies), By Channel (Providers, Self-Referred Individuals), By Type of Service (Risk Assessment, Pharmacogenomics, Other Genetic Pediatric Care Counseling Services), By Application (Proactive Risk Assessment, GC For Intent-to-Treat Patients (ITT), Prenatal and Preconception Care, Other), By Target Population Segment (General Population, Patient Population) and By Level of Service (Pre-counseling Support, Post Counseling Support) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

China Genetic Counseling Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

China Genetic Counseling Market Summary

As per Market Research Future analysis, the China genetic counseling market size was estimated at 128.81 USD Million in 2024. The China genetic counseling market is projected to grow from 147.49 USD Million in 2025 to 571.36 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 14% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The China genetic counseling market is experiencing robust growth driven by technological advancements and increasing awareness of genetic disorders.

  • The largest segment in the China genetic counseling market is prenatal genetic counseling, while the fastest-growing segment is oncology genetic counseling.
  • There is a notable rise in demand for genetic testing, reflecting a broader trend towards personalized medicine.
  • Integration of technology in counseling services is enhancing the efficiency and accessibility of genetic counseling.
  • Key market drivers include increasing awareness of genetic disorders and government support through policy initiatives.

Market Size & Forecast

2024 Market Size 128.81 (USD Million)
2035 Market Size 571.36 (USD Million)
CAGR (2025 - 2035) 14.5%

Major Players

Myriad Genetics (US), Invitae Corporation (US), Ambry Genetics (US), GeneDx (US), Fulgent Genetics (US), 23andMe (US), Color Genomics (US), Natera (US)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

China Genetic Counseling Market Trends

The genetic counseling market is experiencing notable growth. This growth is driven by increasing awareness of genetic disorders and advancements in genomic technologies. As individuals become more informed about their health and the potential hereditary risks, the demand for genetic counseling services is likely to rise. This trend is further supported by the integration of genetic testing into routine healthcare, allowing for early detection and personalized treatment plans. Additionally, the growing prevalence of chronic diseases and genetic conditions in the population appears to be a significant factor influencing this market's expansion. Moreover, the regulatory environment in China is evolving, with government initiatives aimed at promoting genetic research and healthcare innovation. These policies may facilitate the establishment of more genetic counseling centers and enhance the accessibility of services. The collaboration between healthcare providers and genetic counselors is also expected to strengthen, fostering a more comprehensive approach to patient care. As the market continues to develop, it seems poised to play a crucial role in the future of healthcare, emphasizing the importance of genetic insights in disease prevention and management.

Rising Demand for Genetic Testing

The increasing availability and affordability of genetic testing services are driving the demand for genetic counseling. As more individuals seek to understand their genetic predispositions, the need for professional guidance in interpreting test results becomes essential. This trend indicates a shift towards proactive health management.

Integration of Technology in Counseling Services

The adoption of telehealth and digital platforms in the genetic counseling market is transforming how services are delivered. Remote consultations and online resources enhance accessibility, allowing patients to receive support regardless of their location. This technological integration may improve patient engagement and satisfaction.

Focus on Preventive Healthcare

There is a growing emphasis on preventive healthcare within the genetic counseling market. As awareness of the benefits of early intervention increases, more individuals are likely to seek genetic counseling to assess their risks. This trend suggests a proactive approach to health, aiming to reduce the incidence of genetic disorders.

China Genetic Counseling Market Drivers

Rising Incidence of Hereditary Diseases

The rising incidence of hereditary diseases is a critical factor driving the genetic counseling market. In China, the prevalence of conditions such as thalassemia and cystic fibrosis has prompted increased attention to genetic counseling services. Reports indicate that approximately 1 in 300 births may be affected by a hereditary condition, highlighting the urgent need for effective counseling. As families become more aware of the risks associated with hereditary diseases, the demand for genetic counseling is likely to surge. This trend not only emphasizes the importance of early intervention but also positions genetic counseling as an essential component of public health strategies aimed at reducing the burden of hereditary diseases.

Government Support and Policy Initiatives

Government support plays a pivotal role in shaping the genetic counseling market. In China, various policy initiatives aimed at improving healthcare access and promoting genetic research have emerged. The government has allocated substantial funding, estimated at over $500 million, to enhance genetic testing and counseling services. This financial backing is expected to facilitate the establishment of more counseling centers and improve the quality of services offered. Furthermore, regulatory frameworks are being developed to ensure the ethical use of genetic information, which may bolster public trust in genetic counseling. As a result, the genetic counseling market is likely to expand, driven by these supportive measures.

Growing Interest in Personalized Medicine

The growing interest in personalized medicine is emerging as a significant driver for the genetic counseling market. As healthcare shifts towards tailored treatment plans based on individual genetic profiles, the demand for genetic counseling services is likely to rise. In China, the personalized medicine market is projected to reach $10 billion by 2027, indicating a robust growth trajectory. This trend encourages individuals to seek genetic counseling to understand their unique genetic makeup and its implications for health management. Consequently, the genetic counseling market is expected to expand as more healthcare providers integrate genetic insights into their practice, fostering a more personalized approach to patient care.

Increasing Awareness of Genetic Disorders

The rising awareness of genetic disorders among the population is a crucial driver for the genetic counseling market. Educational initiatives and public health campaigns have contributed to a better understanding of genetic conditions, leading to increased demand for counseling services. In China, it is estimated that around 1 in 10 individuals may be affected by a genetic disorder, which underscores the need for genetic counseling. As more people become informed about the implications of genetic testing, the market is likely to experience significant growth. This heightened awareness not only encourages individuals to seek counseling but also promotes preventive measures, thereby enhancing the overall health landscape in the country.

Technological Advancements in Genetic Testing

Technological advancements in genetic testing are significantly influencing the genetic counseling market. Innovations such as next-generation sequencing (NGS) and bioinformatics tools have made genetic testing more accessible and affordable. In China, the cost of genetic testing has decreased by approximately 30% over the past few years, making it more appealing to a broader audience. These advancements not only enhance the accuracy of tests but also streamline the counseling process, allowing genetic counselors to provide more precise information to clients. As technology continues to evolve, it is anticipated that the genetic counseling market will benefit from increased efficiency and improved patient outcomes.

Market Segment Insights

By Counseling Approach: Integrated (Largest) vs. Independent (Fastest-Growing)

In the China genetic counseling market, the Integrated approach currently represents the largest share, characterized by its inclusion within broader healthcare services that provide comprehensive genetic support. This model appeals to clients seeking a seamless experience that combines genetic counseling with other medical services, ensuring holistic care. On the other hand, Independent genetic counseling is emerging rapidly, driven by a growing demand for personalized and focused genetic services. This segment is finding traction as individuals seek specialized advice without the constraints of a broader healthcare system. Moreover, the rise of telehealth has also catalyzed this segment's growth, allowing consultants to reach a wider audience.

Integrated: (Dominant) vs. Discretionary Genetic Counseling (Emerging)

The Integrated counseling approach predominates the market, effectively merging genetic counseling with other healthcare disciplines, thus offering extensive resources and multidisciplinary support. This integration facilitates patient accessibility and promotes better health outcomes. Conversely, Discretionary Genetic Counseling is gaining momentum as a niche offering that caters to clients with specific genetic concerns or interests. Clients opting for this service often seek tailored advice for unique situations, emphasizing the demand for personalization in healthcare. This emerging segment is particularly appealing to tech-savvy individuals who prefer flexible and consultative measures for their genetic inquiries.

By Key Players Business Model: Core Genetic Counseling Companies (Largest) vs. Direct-to-Consumer Genetic Testing Companies (Fastest-Growing)

In the China genetic counseling market, the distribution of market share is primarily dominated by core genetic counseling companies, which form the backbone of the industry, providing conventional genetic counseling services. Direct-to-consumer genetic testing companies are rapidly gaining traction among the population, appealing to tech-savvy consumers seeking personalized health insights while bypassing traditional healthcare pathways. The growth of clinical genetic testing companies is steady but lags behind these two segments. The rapid rise of direct-to-consumer genetic testing companies can be attributed to the increasing public awareness of genetic health and the convenience of at-home testing. Additionally, advancements in technology and reduced costs are driving consumer adoption. As society becomes more health-conscious, the demand for genetic information swings towards accessible and user-friendly services, thereby fostering targeted growth in these emerging testing models.

Core Genetic Counseling Companies (Dominant) vs. Direct-to-Consumer Genetic Testing Companies (Emerging)

Core genetic counseling companies are pivotal in the genetic counseling market, offering essential services such as risk assessment and genetic education, which are crucial for informed decision-making in healthcare. Their established reputation, specialized expertise, and trusted relationships with healthcare providers enable them to maintain a dominant position. In contrast, direct-to-consumer genetic testing companies are positioned as emerging players, leveraging innovative technology to reach consumers directly. They appeal to a younger demographic seeking quick and convenient insights into their genetic makeup. However, these companies often lack the comprehensive support that traditional counseling provides, indicating a potential gap in consumer education and understanding that could influence their long-term sustainability.

By Channel: Providers (Largest) vs. Self-Referred Individuals (Fastest-Growing)

In the channel segment of the China genetic counseling market, Providers hold a significant market share as the largest segment. They dominate the landscape due to their established networks and trust among consumers seeking genetic counseling services. This segment benefits from professional healthcare offerings, which attracts clients looking for expertise and accurate guidance in genetic health matters. Conversely, Self-Referred Individuals represent the fastest-growing segment, driven by an increase in public awareness regarding genetic testing and health. As more individuals pursue personal health insights without referral, this segment is rapidly expanding. This trend is propelled by the accessibility of information and a growing culture of proactive health management, fostering greater demand for genetic counseling services among self-referred clients.

Providers: (Dominant) vs. Self-Referred Individuals (Emerging)

Providers in the China genetic counseling market are characterized by established healthcare professionals and organizations that offer structured services. They leverage their credibility and expertise to build trust with clients, ensuring high-quality counseling and support. Their dominant position is cemented by strong relationships with medical institutions. On the other hand, Self-Referred Individuals are emerging as a notable market force, representing individuals seeking genetic counseling independently. This group is increasingly influenced by the rise of digital health platforms and the availability of direct-to-consumer testing options, which empower them to take charge of their genetic health decisions, thereby contributing to significant growth in this segment.

By Type of Service: Risk Assessment (Largest) vs. Pharmacogenomics (Fastest-Growing)

In the China genetic counseling market, the segment values are characterized by a diverse distribution of services. Risk Assessment accounts for the largest share, catering primarily to those seeking preemptive insights into genetic predispositions. Meanwhile, Pharmacogenomics is gaining traction, specifically among healthcare providers emphasizing tailored medical treatments based on individual genetic profiles. The role of Other Genetic Pediatric Care Counseling Services remains crucial, though it supports and complements the primary segments rather than dominating the market share. Growth trends indicate a burgeoning interest in personalized medicine, fueling the rise of Pharmacogenomics. As more individuals become aware of the benefits of such targeted approaches, healthcare facilities are adopting these services at an accelerated pace. The increasing prevalence of genetic disorders and advancements in technology also contribute to the overall growth trajectory in this segment, highlighting a shift towards proactive healthcare management.

Risk Assessment (Dominant) vs. Pharmacogenomics (Emerging)

Risk Assessment serves as the dominant segment in the China genetic counseling market, focusing on evaluating individuals' potential genetic risks through comprehensive testing. This service appeals widely to those with family histories of genetic disorders. In contrast, Pharmacogenomics is an emerging segment that places an emphasis on understanding how an individual's genetic makeup affects their response to medications. This growing interest aligns with the expanding landscape of personalized medicine, as healthcare providers aim to refine treatment plans based on genetic insights. Both segments are crucial but serve distinct needs within the broader scope of genetic counseling, catering to a population increasingly invested in customized health solutions.

By Application: Proactive Risk Assessment (Largest) vs. Prenatal and Preconception Care (Fastest-Growing)

In the application segment of the China genetic counseling market, Proactive Risk Assessment showcases the largest market share, demonstrating a strong preference among consumers for anticipatory health measures. This segment focuses on genetic predispositions and facilitates early detection of potential health issues, appealing to an increasing number of individuals seeking to manage their health proactively. Prenatal and Preconception Care, while currently holding a smaller share, is the fastest-growing segment, driven by rising awareness of genetic factors in reproductive health and the importance of informed family planning. The growth trends within this segment are largely fueled by advancements in genetic testing technology, making it more accessible and affordable. Factors such as increasing birth rates among older parents and heightened public interest in genetic knowledge are further propelling the demand for prenatal and preconception services. Additionally, educational campaigns by healthcare providers and government initiatives to promote genetic counseling are expected to bolster market growth, particularly for this emerging segment.

Proactive Risk Assessment (Dominant) vs. Prenatal and Preconception Care (Emerging)

Proactive Risk Assessment serves as the dominant application in the China genetic counseling market, appealing to a broad audience predominantly interested in longitudinal health strategies. This approach emphasizes the evaluation of genetic risks ahead of time, enabling individuals to make informed decisions regarding their health. As healthcare increasingly emphasizes preventative measures, this application becomes vital, solidifying its market position. On the other hand, Prenatal and Preconception Care is an emerging segment that is witnessing rapid growth due to changing societal norms and increased focus on reproductive health. It involves genetic counseling during pregnancy and family planning, allowing parents to be aware of potential genetic disorders. This emerging segment supports informed reproductive choices, thereby attracting a motivated demographic who prioritize genetic insights.

By Target Population Segment: General Population (Largest) vs. Patient Population (Fastest-Growing)

In the segment of the China genetic counseling market, the General Population constitutes the largest share, reflecting a broad interest in genetic services driven by increased awareness and accessibility. Meanwhile, the Patient Population has emerged as a significant focus, particularly as healthcare providers recognize the critical need for tailored genetic counseling services to enhance patient outcomes and support informed healthcare decisions. Growth trends indicate that the Patient Population is expanding rapidly due to factors including rising chronic disease incidences and the integration of genetic testing in treatment protocols. This segment is driven by advancements in technology, increasing healthcare funding, and a growing emphasis on personalized medicine, which collectively enhance the demand for genetic counseling specialized for patients. Notably, awareness campaigns are also contributing to the increasing acceptance of genetic counseling among patients.

General Population: Dominant vs. Patient Population: Emerging

The General Population segment is characterized by its extensive reach and the foundational role it plays in the China genetic counseling market. This segment includes individuals seeking information on hereditary conditions and preventive measures, signifying a vital educational component. Conversely, the Patient Population is emerging as a vital part of this market, focusing on individuals who require genetic counseling as part of their medical care. This segment often pertains to patients with specific health conditions or family histories that necessitate in-depth genetic analysis. Both segments are crucial, with the General Population offering stability and widespread engagement, while the Patient Population drives innovation and tailored services that address complex health queries.

By Level of Service: Pre-counseling Support (Largest) vs. Post Counseling Support (Fastest-Growing)

In the China genetic counseling market, the distribution of market share is prominently in favor of pre-counseling support, which has established itself as the largest segment. This segment has gained traction due to the increasing awareness and demand for genetic information prior to decision-making in healthcare. On the other hand, post counseling support, although currently a smaller segment, is rapidly gaining ground as more clients seek comprehensive aftercare to better understand their genetic test results and their implications. Growth trends within the level of service segment are driven by heightened consumer awareness about genetic health and the importance of personalized care. The rising number of individuals seeking genetic testing has necessitated enhanced support services that guide them both before and after their tests. Factors contributing to the rapid growth of post counseling support include the increasing number of chronic health conditions, the advancement of genetic technologies, and a shift towards patient-centered healthcare, prompting a need for thorough follow-ups and ongoing support.

Pre-counseling Support (Dominant) vs. Post Counseling Support (Emerging)

Pre-counseling support has emerged as the dominant service level in the China genetic counseling market, offering essential guidance that prepares patients for genetic testing. This segment includes initial consultations, educational resources, and risk assessments aimed at empowering patients with knowledge. Conversely, post counseling support is an emerging segment focusing on follow-up consultations, interpretation of test results, and ongoing psychological support. As patients navigate the complexities of their genetic information, the demand for such post-counseling services is rapidly increasing, highlighting the necessity for continuous patient engagement and education. Both segments play critical roles in enhancing patient experience and ensuring informed decision-making.

Get more detailed insights about China Genetic Counseling Market
Request Free Sample

Key Players and Competitive Insights

The genetic counseling market in China is characterized by a rapidly evolving competitive landscape, driven by increasing awareness of genetic disorders and advancements in genomic technologies. Key players such as Myriad Genetics (US), Invitae Corporation (US), and 23andMe (US) are strategically positioning themselves through innovation and partnerships. Myriad Genetics (US) focuses on expanding its test offerings and enhancing its digital platforms, while Invitae Corporation (US) emphasizes accessibility and affordability in genetic testing. Meanwhile, 23andMe (US) leverages its consumer-oriented approach to engage a broader audience, thereby shaping a competitive environment that prioritizes patient-centric solutions and technological integration.The market structure appears moderately fragmented, with several players vying for market share through localized strategies and optimized supply chains. Companies are increasingly localizing their manufacturing processes to reduce costs and improve service delivery. This trend, coupled with the presence of established players, suggests a competitive dynamic where collaboration and strategic partnerships are essential for growth and market penetration.

In October Myriad Genetics (US) announced a partnership with a leading Chinese healthcare provider to enhance genetic testing services across the region. This collaboration is expected to significantly improve access to genetic counseling and testing, aligning with the growing demand for personalized medicine in China. Such strategic alliances may enhance Myriad's market presence and operational efficiency, reflecting a broader trend of localized partnerships in the industry.

In September Invitae Corporation (US) launched a new suite of genetic tests tailored specifically for the Asian population, addressing unique genetic predispositions. This initiative not only demonstrates Invitae's commitment to inclusivity but also positions the company to capture a larger share of the market by catering to specific demographic needs. The strategic importance of this move lies in its potential to enhance patient engagement and trust, which are critical in the genetic counseling sector.

In August 23andMe (US) expanded its service offerings by integrating AI-driven tools to provide personalized genetic insights to users. This technological advancement is likely to enhance user experience and engagement, setting a new standard for digital interaction in genetic counseling. The integration of AI reflects a broader trend towards digital transformation, which is becoming increasingly vital in maintaining competitive differentiation in the market.

As of November current trends in the genetic counseling market indicate a strong emphasis on digitalization, sustainability, and AI integration. Strategic alliances are increasingly shaping the competitive landscape, allowing companies to leverage shared resources and expertise. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based strategies to a focus on innovation, technology, and supply chain reliability. This shift may redefine how companies approach market entry and customer engagement, ultimately fostering a more dynamic and responsive market environment.

Key Companies in the China Genetic Counseling Market include

Industry Developments

There have been significant developments in the China Genetic Counseling Market recently. The sector is experiencing robust growth, largely driven by increasing awareness and demand for genetic testing and counseling services. Companies such as Wuxi AppTec and BGI are expanding their offerings, particularly in genetic testing technologies, attracting investments that are elevating market valuations. 

This surge is reflective of a broader trend in China, where there is a growing emphasis on personalized medicine and genomics. In September 2023, Yikon Genomics announced a strategic partnership with Kingmed to enhance testing capacities across various regions, reflecting the ongoing collaborations within the industry. 

Moreover, merger and acquisition activities have been notable, with Dongguan Biotech acquiring GeneTalk in July 2023, consolidating their market position and technology access. Additionally, in August 2023, Nanjing Geneseeq Technology entered into a joint venture with WeGene, emphasizing the strategic moves being made for expansion and innovation in genetic counseling services. This dynamic environment indicates a thriving sector that is likely to continue evolving, boosting accessibility to genetic counseling across China.

Future Outlook

China Genetic Counseling Market Future Outlook

The Genetic Counseling Market in China is projected to grow at a 14.5% CAGR from 2025 to 2035, driven by technological advancements, increased awareness, and rising demand for personalized healthcare solutions.

New opportunities lie in:

  • Development of telehealth platforms for remote genetic counseling services.
  • Integration of AI-driven tools for enhanced risk assessment and patient management.
  • Expansion of genetic testing services in collaboration with healthcare providers.

By 2035, the genetic counseling market is projected to achieve substantial growth, reflecting evolving healthcare needs.

Market Segmentation

China Genetic Counseling Market Channel Outlook

  • Providers
  • Self-Referred Individuals

China Genetic Counseling Market Application Outlook

  • Proactive Risk Assessment
  • GC For Intent-to-Treat Patients (ITT)
  • Prenatal and Preconception Care
  • Others

China Genetic Counseling Market Type of Service Outlook

  • Risk Assessment
  • Pharmacogenomics
  • Other Genetic Pediatric Care Counseling Services

China Genetic Counseling Market Level of Service Outlook

  • Pre-counseling Support
  • Post Counseling Support

China Genetic Counseling Market Counseling Approach Outlook

  • Integrated
  • Independent
  • Discretionary Genetic Counseling

China Genetic Counseling Market Target Population Segment Outlook

  • General Population
  • Patient Population

China Genetic Counseling Market Key Players Business Model Outlook

  • Core Genetic Counseling Companies
  • Direct-to-Consumer Genetic Testing Companies
  • Clinical Genetic Testing Companies

Report Scope

MARKET SIZE 2024 128.81(USD Million)
MARKET SIZE 2025 147.49(USD Million)
MARKET SIZE 2035 571.36(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 14.5% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Myriad Genetics (US), Invitae Corporation (US), Ambry Genetics (US), GeneDx (US), Fulgent Genetics (US), 23andMe (US), Color Genomics (US), Natera (US)
Segments Covered Counseling Approach, Key Players Business Model, Channel, Type of Service, Application, Target Population Segment, Level of Service
Key Market Opportunities Integration of telehealth services enhances access to genetic counseling for diverse populations.
Key Market Dynamics Rising demand for personalized healthcare drives growth in genetic counseling services amid evolving regulatory frameworks.
Countries Covered China
Leave a Comment

FAQs

What is the expected market size of the China Genetic Counseling Market by 2024?

The China Genetic Counseling Market is expected to be valued at 103.2 million USD by 2024.

What will the market size reach by 2035?

By 2035, the China Genetic Counseling Market is projected to grow to 634.7 million USD.

What is the expected CAGR for the China Genetic Counseling Market during the forecast period?

The market is expected to grow at a CAGR of 17.955 percent from 2025 to 2035.

Which counseling approach is projected to dominate the market by value?

The Integrated counseling approach is anticipated to dominate the market, valued at 254.0 million USD in 2035.

What is the value of the Independent counseling approach in 2024?

The Independent counseling approach is valued at 35.2 million USD in 2024.

What is the forecasted market size for Discretionary Genetic Counseling by 2035?

The Discretionary Genetic Counseling segment is expected to reach 157.7 million USD by 2035.

Who are some major players in the China Genetic Counseling Market?

Key players in the market include Wuxi AppTec, GeneTalk, and Yikon Genomics.

What region shows significant potential for growth in the Genetic Counseling Market?

The overall China region exhibits substantial growth potential in the Genetic Counseling Market.

What could be considered a key driver for the growth of the market?

Increasing awareness and demand for personalized healthcare solutions are key drivers for market growth.

What are the challenges faced by the China Genetic Counseling Market?

Challenges include regulatory hurdles and the need for skilled professionals in genetic counseling.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓